Archives

Tripment Health and Walnut Announce Strategic Partnership

Tripment Health and Walnut Announce Strategic Partnership

New Partnership Providers Groundbreaking Way for Patients To Book And Pay For Healthcare In An Easy, Accessible, And Affordable Manner

Tripment Health, a leading nationwide digital healthcare marketplace that provides access to affordable healthcare, and Walnut, a leading payment method that provides consumers a transparent way to pay for healthcare over time, announced a partnership that integrates Walnut’s buy-now-pay-later product into Tripment’s booking platform.

Tripment Health is a nationwide digital healthcare ecosystem offering cash pay patients easy access to quality, affordable care with transparent and upfront prices thus eliminating surprise medical bills. Patients can choose from thousands of services and procedures ranging from telehealth or in-person vists, diagnostic imaging services, discount prescriptions and lab test.

Read More: Optimvia and Ginkgo Bioworks Announce Partnership to Manufacture Biosynthetic Heparin

“There are over 91 million uninsured and underinsured Americans who are forced to pay for a majority of their healthcare out-of-pocket,” said Alex Radunsky, Chief Executive Officer at Tripment Health. “Our online marketplace provides these Americans access to affordable high-quality care with full price transparency. We are thrilled to partner with Walnut to provide patients with additional financial flexibility to receive the care they need.”

“Patients are increasingly looking for easier and more flexible ways to pay, and platforms that enable these types of payment options can rapidly see adoption while increasing patient satisfaction ” said Roshan Patel, Walnut’s Chief Executive Officer. “We’re excited to partner with Tripment Health to help ignite their growth, while also bringing Walnut’s convenient and transparent pay-over-time option to even more patients!”

Patients can now instantly book appointments on Tripment Health and pay in monthly installments over 3, 6, or 12 months with interest rates as low as 0% APR. For example, a $500 purchase might cost $100 per month over 5 months at 0% APR.

Read More: Jubilant Therapeutics Announces FDA Clearance of IND for JBI-802, a Novel Dual LSD1 and HDAC6 Inhibitor, for Treatment of Solid Tumors